Medication reconciliation: comparing a customized medication history form to a standard medication form in a specialty clinic (CAMPII 2).

Background: Medication history forms completed by patients are an essential part of the medication reconciliation process.

Objective: In a crossover prospective study, investigators compared the accuracy and acceptability of a "fill-in-the blank" medication history form (USUAL) to a customized form (CUSTOM) that contained a checklist of the 44 most frequently prescribed diabetes clinic medications.

Methods: The content of both forms was compared to a "gold-standard" medication list compiled by a clinical pharmacist who conducted a medication history and reviewed pharmacy profiles and medical chart.

The "metabolic syndrome" is less useful than random plasma glucose to screen for glucose intolerance.

Aims: To compare the utility of metabolic syndrome (MetS) to random plasma glucose (RPG) in identifying people with diabetes or prediabetes.

Methods: RPG was measured and an OGTT was performed in 1155 adults. Test performance was measured by area under the receiver-operating-characteristic curve (AROC).

Random plasma glucose in serendipitous screening for glucose intolerance: screening for impaired glucose tolerance study 2.

Background: With positive results from diabetes prevention studies, there is interest in convenient ways to incorporate screening for glucose intolerance into routine care and to limit the need for fasting diagnostic tests.

Objective: The aim of this study is to determine whether random plasma glucose (RPG) could be used to screen for glucose intolerance.

Design: This is a cross-sectional study.

An informatics model for clinical research--screening for impaired glucose tolerance study.

A major challenge for large scale, multi-site research studies is the time-sensitive tracking of numerous subjects, samples and results through multiple encounters and processes, by many team members in several different locations. This may be compounded by collaborations with other studies to share samples, data collection and subjects. The Screening for Impaired Glucose Tolerance (SIGT) study has met this challenge by developing a secure, informatics system with web and client server interfaces.